Literature DB >> 26317596

Opium as a Risk Factor for Bladder Cancer: A Population-based Case-control Study in Iran.

Morteza Akbari1, Ahmad Naghibzadeh-Tahami2, Narges Khanjani3, Mohammad Reza Baneshi4, Elham Kamali5, Maryam Hesampour5, Bahman Nazemzadegan6, Ali-Akbar Haghdoost7.   

Abstract

BACKGROUND: Bladder cancer (BC) is the most common genitourinary system malignancy in humans. Consumption of opium and its derivatives, maybe a risk factor possibly in Iran. The aim of this study was to investigate the relationship between consumption of opium and its derivatives and the incidence of BC.
METHODS: In an individually matched case-control study in Shiraz (located in the south of Iran), 198 patients with BC and 396 healthy individuals (matched in age, sex and residence (urban/rural)) were investigated. Data about consumption of opium and its derivatives, tobacco, alcohol and diet were collected using a structured valid and reliable questionnaire. Crude and adjusted odds ratios (ORs) were computed using conditional logistic regression models.
RESULTS: Opium consumption was associated with an increased risk of BC with an adjusted OR = 3.9 (95% CI: 1.2 - 12.0). Moreover, a considerable dose-response relationship was observed between the opium consumption and its derivatives and the incidence of BC; comparing to no users, the odds ratios of low and high consumptions were 3.3 (95% CI: 0.5 - 23.1) and 4.9 (95% CI: 1.1 - 21.9) respectively.
CONCLUSION: Opium consumption can be a potential strong risk factor for BC in Iran.

Entities:  

Mesh:

Year:  2015        PMID: 26317596     DOI: 0151809/AIM.004

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN: 1029-2977            Impact factor:   1.354


  12 in total

Review 1.  Opium Use and Cancer Risk: A Comprehensive Systematic Review and Meta-Analysis of Observational Studies.

Authors:  Masoume Mansouri; Sina Naghshi; Mahbobeh Parsaeian; Sadaf G Sepanlou; Hossein Poustchi; Zahra Momayez Sanat; Omid Sadeghi; Akram Pourshams
Journal:  Int J Clin Pract       Date:  2022-02-18       Impact factor: 3.149

2.  Opium use and risk of bladder cancer: a multi-centre case-referent study in Iran.

Authors:  Maryam Hadji; Hamideh Rashidian; Maryam Marzban; Ahmad Naghibzadeh-Tahami; Mahin Gholipour; Elham Mohebbi; Roya Safari-Faramani; Monireh Sadat Seyyedsalehi; Bayan Hosseini; Mahdieh Bakhshi; Reza Alizadeh-Navaei; Lida Ahmadi; Abbas Rezaianzadeh; Abdolvahab Moradi; Alireza Ansari-Moghaddam; Azim Nejatizadeh; Soodabeh ShahidSales; Farshad Zohrabi; Reza Mohammadi; Mohammad Reza Nowroozi; Hossein Poustchi; Dariush Nasrollahzadeh; Farid Najafi; Ali Akbar Haghdoost; Afarin Rahimi-Movaghar; Arash Etemadi; Mohammad Ali Mohagheghi; Reza Malekzadeh; Paul Brennan; Joachim Schüz; Paolo Boffetta; Elisabete Weiderpass; Farin Kamangar; Kazem Zendehdel; Eero Pukkala
Journal:  Int J Epidemiol       Date:  2022-06-13       Impact factor: 9.685

3.  Comparing the Efficacy of Methadone and Tincture of Opium in Controlling Agitation Caused by Withdrawal Syndrome in Opium-Addicted Patients in the Intensive Care Unit: A Randomized Trial Study.

Authors:  Seyed Mojtaba Sohrevardi; Mostafa Pournamdari; Razieh Salimi; Farhad Sarrafzadeh; Mehdi Ahmadinejad
Journal:  Addict Health       Date:  2020-04

Review 4.  Opium and bladder cancer: A systematic review and meta-analysis of the odds ratios for opium use and the risk of bladder cancer.

Authors:  Mahdi Afshari; Ghasem Janbabaei; Mohammad Amin Bahrami; Mahmood Moosazadeh
Journal:  PLoS One       Date:  2017-06-06       Impact factor: 3.240

Review 5.  Targeting the mu-Opioid Receptor for Cancer Treatment.

Authors:  Hao Zhang; Di Zhou; Jiahui Gu; Mengdi Qu; Kefang Guo; Wankun Chen; Changhong Miao
Journal:  Curr Oncol Rep       Date:  2021-08-03       Impact factor: 5.075

6.  Can Opium Use Contribute to a Higher Risk of Colorectal Cancers? A Matched Case-control Study in Iran.

Authors:  Ahmad Naghibzadeh-Tahami; Vahid Yazdi Feyzabadi; Narges Khanjani; Ahad Ashrafi-Asgarabad; Hosniyeh Alizaeh; Vahid Reza Borhaninejad; Mohammad Moradi-Joo; Masoud Zeinali; Mohammad Javad Zahedi; Mahmoud Aghaee-Afshar; Ali Akbar Haghdoost
Journal:  Iran J Public Health       Date:  2016-10       Impact factor: 1.429

7.  Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.

Authors:  Sajjad Mohammad Ganji; Massoud Saidijam; Razieh Amini; Seyed Habibollah Mousavi-Bahar; Nooshin Shabab; Saman Seyedabadi; Ali Mahdavinezhad
Journal:  Int J Mol Cell Med       Date:  2017-07-08

8.  Is opium use associated with an increased risk of lung cancer? A case-control study.

Authors:  Ahmad Naghibzadeh-Tahami; Maryam Marzban; Vahid Yazdi-Feyzabadi; Shahryar Dabiri; Shokrollah Mohseni; Reza Abbasi Rayeni; Mitra Samareh Fekri; Mohammad Hasan Larizadeh; Behnaz Karimpour; Narges Khanjani
Journal:  BMC Cancer       Date:  2020-08-26       Impact factor: 4.430

Review 9.  Bladder Cancer in Iran: An Epidemiological Review.

Authors:  Khadijeh Kalan Farmanfarma; Neda Mahdavifar; Hamid Salehiniya
Journal:  Res Rep Urol       Date:  2020-03-05

Review 10.  Opioids in Cancer Development, Progression and Metastasis: Focus on Colorectal Cancer.

Authors:  Adrian Szczepaniak; Jakub Fichna; Marta Zielińska
Journal:  Curr Treat Options Oncol       Date:  2020-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.